Published in Ann Pharmacother on December 15, 2003
There is (still) too much aluminium in infant formulas. BMC Pediatr (2010) 0.94
Acute phosphate restriction leads to impaired fracture healing and resistance to BMP-2. J Bone Miner Res (2010) 0.90
Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis (2009) 2.65
Publication metrics and record of pharmacy practice chairs. Ann Pharmacother (2009) 2.03
Pharmacokinetic comparison of acetaminophen elixir versus suppositories in vaccinated infants (aged 3 to 36 months): a single-dose, open-label, randomized, parallel-group design. Clin Ther (2013) 2.01
Management of childhood onset nephrotic syndrome. Pediatrics (2009) 1.87
Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy. Ann Neurol (2010) 1.81
New indices in scholarship assessment. Am J Pharm Educ (2009) 1.73
Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study. J Pediatr (2009) 1.72
Prevalence of vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis referred to a pediatric metabolic bone clinic. Pediatrics (2008) 1.69
Residency requirement for pharmacists providing direct patient care. Ann Pharmacother (2010) 1.58
Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int (2012) 1.52
Contradictions in contraindications for drug-drug interactions. Ann Pharmacother (2011) 1.46
Clinical uses of dexmedetomidine in pediatric patients. Paediatr Drugs (2008) 1.43
Selective serotonin-reuptake inhibitors and suicidal ideation and behavior in children. Am J Health Syst Pharm (2005) 1.41
Herbal weight-loss supplement misadventures per a regional poison center. Ann Pharmacother (2004) 1.38
The evolution of The Annals Online. Ann Pharmacother (2003) 1.38
Update in medical education for pediatrics: insights and directions from the 2010 literature. Med Educ Online (2012) 1.38
Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease. Am J Hematol (2011) 1.19
Management patterns of childhood-onset nephrotic syndrome. Pediatr Nephrol (2009) 1.16
Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf (2004) 1.16
Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Kidney Int (2011) 1.09
Pediatric chronic kidney disease and the process of health care transition. Semin Nephrol (2009) 1.08
Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. Pediatr Nephrol (2008) 1.08
A standard, noninvasive monitoring of hematocrit algorithm improves blood pressure control in pediatric hemodialysis patients. Clin J Am Soc Nephrol (2007) 1.04
Pharmacologic treatment of chronic pediatric hypertension. Paediatr Drugs (2005) 1.04
Fellows as teachers: a model to enhance pediatric resident education. Med Educ Online (2011) 0.98
Association between race, depression, and antiretroviral therapy adherence in a low-income population with HIV infection. J Gen Intern Med (2012) 0.97
Population pharmacokinetics of amlodipine in hypertensive children and adolescents. J Clin Pharmacol (2006) 0.96
Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study. Health Qual Life Outcomes (2013) 0.96
Body mass index in primary and secondary pediatric hypertension. Pediatr Nephrol (2004) 0.95
Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol (2014) 0.94
Computerized clinical decision support for medication prescribing and utilization in pediatrics. J Am Med Inform Assoc (2012) 0.94
Factors influencing pediatric nephrology trainee entry into the workforce. Clin J Am Soc Nephrol (2010) 0.94
Deliberate practice improves pediatric residents' skills and team behaviors during simulated neonatal resuscitation. Clin Pediatr (Phila) (2013) 0.94
Management of botulism. Ann Pharmacother (2003) 0.93
Pharmaceutical science faculty publication records at research-intensive pharmacy colleges and schools. Am J Pharm Educ (2012) 0.93
Ketamine for conscious sedation in pediatric emergency care. Pharmacotherapy (2005) 0.93
Francke's legacy--40 years of clinical pharmacy. Ann Pharmacother (2007) 0.92
Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis. J Dermatolog Treat (2006) 0.91
Prevalence of sleep disturbances in children and adolescents with chronic kidney disease. Pediatr Nephrol (2011) 0.90
Stability of cefazolin sodium in four heparinized and non-heparinized dialysate solutions at 38 degrees C. Perit Dial Int (2006) 0.90
Trends in medication prescribing for pediatric sleep difficulties in US outpatient settings. Sleep (2007) 0.89
Serotonin syndrome following a single 50 mg dose of sertraline in a child. Clin Toxicol (Phila) (2008) 0.89
Utility of cystatin C to monitor renal function in Duchenne muscular dystrophy. Muscle Nerve (2009) 0.89
Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes. Ann Pharmacother (2011) 0.89
Clinical trial of extended-release felodipine in pediatric essential hypertension. Pediatr Nephrol (2003) 0.89
Appropriateness of commercially available and partially customized medication dosing alerts among pediatric patients. J Am Med Inform Assoc (2013) 0.89
Abnormal left ventricular mass and aortic distensibility in pediatric dialysis patients. Pediatr Nephrol (2004) 0.88
Advancing patient care through innovative practice: the Clinical Partners Program. Am J Health Syst Pharm (2005) 0.88
A 9-state analysis of designer stimulant, "bath salt," hospital visits reported to poison control centers. Ann Emerg Med (2013) 0.88
Tips for writing and publishing an article. Ann Pharmacother (2008) 0.86
Efficacy and safety of hypoglycemic drugs in children with type 2 diabetes mellitus. Pharmacotherapy (2005) 0.86
Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder. Clin Ther (2003) 0.85
Learning management systems: technology to measure the medical knowledge competency of the ACGME. Med Educ (2004) 0.84
Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV. Ann Pharmacother (2004) 0.84
Intermittent intravenous sildenafil for pulmonary hypertension management in neonates and infants. Am J Health Syst Pharm (2013) 0.83
Medication management of irritable bowel syndrome. Digestion (2014) 0.83
Azithromycin for improving pulmonary function in cystic fibrosis. Ann Pharmacother (2004) 0.83
Complementary and alternative medicine for upper-respiratory-tract infection in children. Am J Health Syst Pharm (2006) 0.82
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures. Int J Pharm Compd (2016) 0.82
The accuracy and health risks of a voiding cystourethrogram after a febrile urinary tract infection. J Pediatr Urol (2010) 0.82
Self-assessment on the competencies and reported improvement priorities for pediatrics residents. J Grad Med Educ (2012) 0.81
In Pursuit of Meaningful Use of Learning Goals in Residency: A Qualitative Study of Pediatric Residents. Acad Med (2016) 0.81
Prescribing patterns for the outpatient treatment of constipation in the United States. Dig Dis Sci (2010) 0.81
Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study. Clin Ther (2006) 0.80
Multicenter trial of everolimus in pediatric renal transplant recipients: results at three year. Pediatr Transplant (2008) 0.80
Significance of heritability in primary and secondary pediatric hypertension. Am J Hypertens (2005) 0.80
Obstacles to the prescribing of growth hormone in children with chronic kidney disease. Pediatr Nephrol (2008) 0.80
Evaluation of the Be Poison Smart! poison prevention intervention. Clin Toxicol (Phila) (2006) 0.79
Medication use patterns and health outcomes among patients using a subsidized prescription drug program. J Am Pharm Assoc (2003) (2005) 0.79
Safety and pharmacokinetics of ribavirin for the treatment of la crosse encephalitis. Pediatr Infect Dis J (2011) 0.79
The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol (2015) 0.79
EMLA for painful procedures in infants. J Pediatr Health Care (2005) 0.79
Atomoxetine-induced hepatitis in a child. Clin Toxicol (Phila) (2007) 0.79
Quality-of-Life Measurements in Juvenile Rheumatoid Arthritis Patients Treated with Etanercept. Clin Drug Investig (2003) 0.79
Medication choice and associated health care outcomes and costs for patients with acne and acne-related conditions in the United States. J Drugs Dermatol (2011) 0.79
Steroid avoidance using sirolimus and cyclosporine in pediatric renal transplantation: one year analysis. Pediatr Transplant (2009) 0.78
Growth in chronic kidney disease. Adv Chronic Kidney Dis (2011) 0.78
Pharmacologic therapy for HIV-associated lipodystrophy. Ann Pharmacother (2004) 0.78
Prescribing Patterns for Outpatient Treatment of Constipation, Irritable Bowel Syndrome-Related Constipation, and Opioid-Induced Constipation: A Retrospective Cross-Sectional Study. J Manag Care Spec Pharm (2015) 0.78
Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors. Ann Pharmacother (2003) 0.78
Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study. Pediatr Nephrol (2003) 0.78
The impact of an interactive Web-based module on residents' knowledge and clinical practice of injury prevention. Clin Pediatr (Phila) (2011) 0.78
The effects of hypertension on cognitive function in children and adolescents. Int J Pediatr (2012) 0.78
Steroid-sensitive nephrotic syndrome and juvenile idiopathic arthritis. Pediatr Nephrol (2002) 0.78
Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescents. Pharmacotherapy (2004) 0.77
Persuading physicians to test their patients' level of kidney functioning: the effects of message frame and point of view. Health Commun (2010) 0.77
Children and adolescent exposures to atomoxetine hydrochloride reported to a poison control center. Clin Toxicol (Phila) (2006) 0.77
Prescribing trends for the outpatient treatment of adolescents and young adults with type 2 diabetes mellitus. J Manag Care Pharm (2012) 0.77
Prior authorization of newer insomnia medications in managed care: is it cost saving? J Clin Sleep Med (2007) 0.77